Longlong Si
Impact in
- Pharmacology top 2%
- Pharmacological Effects of Natural Compounds
- Microbial Natural Products and Biosynthesis
- Biotechnology top 5%
Papers in
-
- Pharmacological Effects of Natural Compounds 7
- Microbial Natural Products and Biosynthesis 5
-
- Toxin Mechanisms and Immunotoxins 6
Longlong Si
49 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Pharmacology 257
- Biotechnology 130
- Pharmacology 247
- Toxicology 50
- Immunology 294
Countries citing papers authored by Longlong Si
This map shows the geographic impact of Longlong Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longlong Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longlong Si more than expected).
Fields of papers citing papers by Longlong Si
This network shows the impact of papers produced by Longlong Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longlong Si. The network helps show where Longlong Si may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Longlong Si, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 18 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 38 | |
| 8 | 2023 | 4 | |
| 9 | Mechanical control of innate immune responses against viral infection revealed in a human lung alveolus chip Hit paper breakdown → | 2022 | 107 |
| 10 | 2022 | 3 | |
| 11 | 2018 | 29 | |
| 12 | 2017 | 12 | |
| 13 | 2017 | 7 | |
| 14 | 2017 | 35 | |
| 15 | 2017 | 36 | |
| 16 | 2016 | 49 | |
| 17 | 2015 | 21 | |
| 18 | 2015 | 93 | |
| 19 | 2015 | 59 | |
| 20 | 2015 | 94 |
About Longlong Si
Longlong Si is a scholar working on Pharmacology, Immunology, Molecular Biology, Hepatology and Pharmacology, having authored 49 papers that have together received 1.8k indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (12 papers), Influenza Virus Research Studies (8 papers), Pharmacological Effects of Natural Compounds (7 papers), RNA and protein synthesis mechanisms (6 papers), Toxin Mechanisms and Immunotoxins (6 papers), Virus-based gene therapy research (5 papers), Microbial Natural Products and Biosynthesis (5 papers) and 3D Printing in Biomedical Research (4 papers). The work is most often cited by research in Pharmacology (257 citations), Biotechnology (130 citations), Pharmacology (247 citations), Toxicology (50 citations) and Immunology (294 citations). Longlong Si has collaborated with scholars based in China, United States and France. Frequent co-authors include Demin Zhou, Lihe Zhang, Sulong Xiao, Yufei Wang, Wenhan Lin, Zhenyu Tian, Donald E. Ingber, Ge Fu, Yongmin Zhang and Yiming Wu. Their work appears in journals such as European Journal of Medicinal Chemistry, Advanced Healthcare Materials, International Journal of Molecular Sciences, MedChemComm and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.